(Q36786231)

16 August 2017

0 references

1 reference

title

Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review (English)

1 reference

16 August 2017

1 reference

1 reference

Shobha Phansalkar

1

1 reference

16 August 2017

Jennifer M Hoffman

series ordinal

2

1 reference

16 August 2017

Jonathan R Nebeker

series ordinal

3

1 reference

16 August 2017

John F Hurdle

series ordinal

4

1 reference

16 August 2017

1 April 2007

1 reference

American Journal of Health-System Pharmacy

16 August 2017

1 reference

16 August 2017

64

1 reference

16 August 2017

8

1 reference

16 August 2017

842-849

1 reference

Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients

16 August 2017

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Computerized surveillance of adverse drug reactions in hospital: implementation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Electronically screening discharge summaries for adverse medical events

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

High rates of adverse drug events in a highly computerized hospital

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Using computerized data to identify adverse drug events in outpatients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Epidemiology, comparative methods of detection, and preventability of adverse drug events.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Readmissions and adverse drug reactions in internal medicine: the economic impact.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Clinical pharmacists and inpatient medical care: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Incidence and preventability of adverse drug events in nursing homes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Identification of adverse drug reactions in geriatric inpatients using a computerised drug database

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

Computerized survelliance of adverse drug reactions in hospital: pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

The Nature of Adverse Events in Hospitalized Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060335

31 March 2020

Identifiers

DOI

10.2146/AJHP060335

1 reference

16 August 2017

1 reference